Zhao, Jie
Zheng, Wei
Xuan, Nan-xian
Zhou, Qi-chao
Wu, Wei-bing
Cui, Wei
Tian, Bao-ping
Funding for this research was provided by:
the Fundamental Research Funds for the Central Universities of China (226-2022-00105)
the National Natural Science Foundation of China (82172163)
Article History
Received: 20 November 2023
Accepted: 10 January 2024
First Online: 23 January 2024
Declarations
:
: This retrospective observational study was conducted at the Second Affiliated Hospital, Zhejiang University School of Medicine. Patients who were admitted to all of the ICUs from January 2011 to December 2020 and treated with MV were eligible. The trial was approved by the hospital’s ethics committee of the Second Affiliated Hospital, Zhejiang University School of Medicine (2021 Ethical Review No. 0210) and the Informed Consent in the retrospective study was waived by the the hospital’s ethics committee of the Second Affiliated Hospital, Zhejiang University School of Medicine. This trial wasregistered in the Chinese Clinical Trial Registry (ChiCTR2100043905).
: Not applicable.
: The authors declare no competing interests.